FDA Inspection 777067 — Hospira, Inc.
The FDA completed an inspection of Hospira, Inc. on April 13, 2012 in Lake Forest, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 13, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lake Forest, IL (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)